29 results
424B5
CELU
Celularity Inc - Ordinary Shares
28 Jul 23
Prospectus supplement for primary offering
4:24pm
this necessary capital or address our liquidity needs may force us to delay, limit or terminate our operations, make further reductions in our workforce … announced reprioritization of efforts, which resulted in a reduction of approximately one-third of our workforce as of March 2023.
Our Celularity
424B3
CELU
Celularity Inc - Ordinary Shares
2 Jun 23
Prospectus supplement
5:00pm
in our workforce, discontinue our commercialization efforts for our biomaterials products as well as other clinical trial programs, liquidate all … reprioritization of efforts which resulted in a reduction of approximately one-third of our workforce as of March 2023.
Our Celularity IMPACT platform
424B5
blel79
6 Apr 23
Prospectus supplement for primary offering
9:03pm
424B3
gpqkqq
1 Jun 22
Prospectus supplement
4:06pm
424B3
3kua8ugfvifq97zrib
3 May 22
Prospectus supplement
4:06pm
POS AM
fsyptz82 tn4
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
424B3
hlf9ynddfi24 8a
12 Aug 21
Prospectus supplement
4:21pm
424B3
3t6k9jm8 9chb6
25 Jun 21
Prospectus supplement
12:48pm